831
Participants
Start Date
November 23, 2017
Primary Completion Date
November 11, 2022
Study Completion Date
October 31, 2023
NRTIs
"In SOC arm, choice of NRTIs determined by clinician, guided by either genotypic resistance testing or use of a protocol-specified algorithm for N(t)RTI selection.~In D2N arm, NRTIs are predetermined."
Dolutegravir
50mg tablet by mouth once daily for 96 weeks.
Darunavir
800mg tablet by mouth once daily for 96 weeks.
Ritonavir
100mg tablet by mouth once daily for 96 weeks.
Hospital Dr Diego Paroissien, Isidro Casanova
Perinatal HIV Research Unit (PHRU), Chris Hani Baragwanath Hospital, Soweto
Hospital Interzonal de Agudos San Juan de Dios, La Plata
Clinical HIV Research Unit (CHRU), Wits Health Consotium (Pty) Ltd, Johannesburg
Desmond Tutu HIV Foundation, Cape Town
Institute of Human Virology, Nigeria (IHVN), Abuja
Dr. Cipto Mangunkusumo Hospital, Jakarta
HIV-NAT (The HIV Netherlands Australia Thailand Research Collaboration), Thai Red Cross AIDS Research Centre, Bangkok
Hospital Pulau Pinang, George Town
Bamrasnaradura Infectious Diseases Institute, Nonthaburi
Instituto Nacional de Ciencias Medicas y Nutriciòn Salvador Zubiran, Mexico City
Morales Vargas Centro de Investigacion SC, León
Srinagarind Hospital, Khon Kaen University, Khon Kaen
Hospital Civil de Guadalajara, Guadalajara
Dr Sardjito Hospital, Yogyakarta
Chiangrai Prachanukroh Hospital, Chiang Rai
University of Malaya Medical Centre, Kuala Lumpur
Dr. Soetomo Hospital, Surabaya
RSUP Dr. Wahidin Sudirohusodo, Makassar
ASISTENCIA Cientifica De Alta Complejidad S.A.S., Bogotá
CART CRS, VHS Hospital, Chennai
Hospital San Borja-Arriaran, Santiago
Hospital G de Agudos JM Ramos Mejia, Buenos Aires
CAICI, Rosario
Laboratório de Pesquisa Clinica Em Hiv/Aids - Instituto Nacional de Infectologia - Fiocruz, Rio de Janeiro
Centre de traitementambulatoire de Donka ( Hopital de jour), Conakry
University of Sciences, Techniques and Technologies of Mali, University Clinical Research Center (UCRC), Bamako
University of Zimbabwe Clinical Research Centre, Harare
Lead Sponsor
Collaborators (2)
UNITAID
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
National Health and Medical Research Council, Australia
OTHER
ViiV Healthcare
INDUSTRY
Janssen Pharmaceutica
INDUSTRY
Kirby Institute
OTHER_GOV